Effect of sildenafil and acclimatization on cerebral oxygenation at altitude

被引:13
作者
Chan, CWM
Hoar, H
Pattinson, K
Bradwell, AR
Wright, AD
Imray, CHE
机构
[1] Univ Birmingham, Sch Med, Immunodiagnost Res Lab, Birmingham B15 2TT, W Midlands, England
[2] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Anaesthet, Oxford OX3 9DU, England
[3] Univ Hosp Coventry, Cty Vasc Unit, NHS Trust, Coventry CV2 2DX, W Midlands, England
[4] Univ Hosp Warwickshire, NHS Trust, Coventry CV2 2DX, W Midlands, England
关键词
acclimatization; altitude; cerebral regional oxygen saturation; hypoxia; middle cerebral artery velocity; phosphodiesterase-5; sildenafil (Viagra (R));
D O I
10.1042/CS20050036
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
`Phosphodiesterase-5 inhibitors decrease hypoxic pulmonary vasoconstriction under hypobaric hypoxia, but are not known to affect cerebral blood flow or oxygenation. The present study was designed to evaluate the effect of sildenafil on cerebral haemodynamics during acute exposure to altitude and after acclimatization. Ten subjects were studied 1 and 3 days after rapid ascent to 3480 m before and for two consecutive hours after taking sildenafil (50 mg). Before acclimatization, HR (heart rate) rose at 1 h (76.3 +/- 1.0 beats/min compared with 72.5 +/- 1.5 beats/min at baseline; P < 0.05) and had returned to baseline at 2 h (71.3 +/- 1.1 beats/min; P > 0.05). Mean BP (blood pressure) fell from 96.0 +/- 2.0 mmHg at baseline to 91.7 +/- 2.5 (P < 0.001) at 1 h and 89.8 +/- 1.8 mmHg (P < 0.0001) at 2 h, whereas Sao(2) (arterial oxygen saturation) increased from 83.9 +/- 0.5 % at baseline to 85.3 +/- 0.4 % (P < 0.0001) at 1 h and 85.0 +/- 0.5 % (P < 0.01) at 2 h. MCAV [MCA (middle cerebral artery) velocity] and PETCO2 (end-tidal partial pressure Of CO2) were unchanged, but rSo(2) (regional cerebral oxygen saturation) rose progressively at 1 h (62.7 +/- 0.8 %; P < 0.05) and 2 h (65.3 +/- 0.9 %; P < 0.0001) compared with baseline (59.3 +/- 1.3 %). After 3 days of acclimatization, resting rSo(2) and RMCA (MCA resistance) increased and oxygen delivery fell. Changes in HR and mean BP after sildenafil were similar to day 1, but Sao(2) did not change. However, rSo(2) increased [61.7 +/- 0.9 % at baseline to 65.0 +/- 1.0 % (P < 0.0001) at 1 h and 64.0 +/- 0.9 % (P < 0.001) at 2h], despite a reduction in MCAV [65.3 +/- 1.8 cm/s at baseline to 61.3 +/- 1.5 cm/s (P < 0.01) at 1 h and 60.9 +/- 1.7 cm/s (P < 0.0001) at 2 h] and PETCO2 [4.1 +/- 0.05 kPa at baseline to 4.0 +/- 0.04 kPa at 2 h (P < 0.01)]. These observations suggest that sildenafil improves cerebral oxygenation at altitude. Whereas the early changes before acclimatization may be largely pulmonary in origin, the later observations may be a direct cerebral effect which warrants further study.
引用
收藏
页码:319 / 324
页数:6
相关论文
共 22 条
[11]   Immunohistochemical localization of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in rat tissues [J].
Kotera, J ;
Fujishige, K ;
Omori, K .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2000, 48 (05) :685-693
[12]   Migraine can be induced by sildenafil without changes in middle cerebral artery diameter [J].
Kruuse, C ;
Thomsen, LL ;
Birk, S ;
Olesen, J .
BRAIN, 2003, 126 :241-247
[13]   The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects [J].
Kruuse, C ;
Thomsen, LL ;
Jacobsen, TB ;
Olesen, J .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2002, 22 (09) :1124-1131
[14]   REGIONAL CEREBROVASCULAR OXYGEN-SATURATION MEASURED BY OPTICAL SPECTROSCOPY IN HUMANS [J].
MCCORMICK, PW ;
STEWART, M ;
GOETTING, MG ;
BALAKRISHNAN, G .
STROKE, 1991, 22 (05) :596-602
[15]   Treatment of pulmonary hypertension - Several options exist, but they are expensive and necessitate specialist care [J].
Peacock, AJ .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7394) :835-836
[16]   Changes in cerebral blood flow during and after 48 h of both isocapnic and poikilocapnic hypoxia in humans [J].
Poulin, MJ ;
Fatemian, M ;
Tansley, JG ;
O'Connor, DF ;
Robbins, PA .
EXPERIMENTAL PHYSIOLOGY, 2002, 87 (05) :633-642
[17]  
ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272
[18]  
SEFTEL A, 2002, J UROLOGY, V168, P2318
[19]  
Tauboll E, 1999, AVIAT SPACE ENVIR MD, V70, P692
[20]   Nitric oxide, phosphodiesterase inhibition, and adaption to hypoxic conditions [J].
Wilkins, MR ;
Aldashev, A ;
Morrell, NW .
LANCET, 2002, 359 (9317) :1539-1540